Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 206,165,104 papers from all fields of science
Search
Sign In
Create Free Account
raltegravir potassium
Known as:
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[ (5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Monopotassium Salt
, Potassium, Raltegravir
, Raltegravir Potassium [Chemical/Ingredient]
The orally bioavailable potassium salt of a human immunodeficiency virus (HIV) integrase strand transfer inhibitor (HIV-1 INSTI) with HIV-1 antiviral…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Broader (3)
Anti-HIV Agents
HIV Integrase Inhibitors
raltegravir
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Narrower (2)
Isentress
MK 0518
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Spectrophotometric Estimation of Raltegravir Potassium in Tablets
P. Kore
,
M. M. Gamepatil
,
H. Nimje
,
K. Baheti
Indian journal of pharmaceutical sciences
2014
Corpus ID: 5444814
Ultra violet spectrophotometric estimation of the raltegravir potassium, an integrase inhibitor antiretroviral agent was…
Expand
2013
2013
Simple Spectrophotometric Method for Estimation of Raltegravir Potassium in Bulk and Pharmaceutical Formulations
G. Bhavar
,
S. Pekamwar
,
Kiran B. Aher
,
S. Chaudhari
2013
Corpus ID: 38139046
A simple, rapid, precise, and economical spectrophotometric method has been developed for quantitative analysis of Raltegravir…
Expand
2012
2012
VALIDATED STABILITY-INDICATING UPLC ASSAY METHOD A ND DEGRADATION BEHAVIOR OF RALTEGRAVIR POTASSIUM
B. V. R. Reddy
,
B. Reddy
,
N. Raman
,
G. Jyothi
,
K. S. Reddy
,
C. Rambabu
2012
Corpus ID: 212537288
2011
2011
Development and Validation of RP-HPLC and HPTLC Chromatographic Methods of Analysis for the Quantitative Estimation of Raltegravir Potassium in Pharmaceutical Dosage Form
T. Sudha
,
P. Shanmugasundram
2011
Corpus ID: 124694554
A high performance liquid chromatography and high performance thin layer liquid chromatography method were developed and…
Expand
2011
2011
Reverse Phase - High Performance Liquid Chromatography and Ultra Violet Spectrophotometric Method for The Estimation of Raltegravir Potassium in Bulk and in Tablet Dosage form
T. Sudha
,
T. Raghupathi
2011
Corpus ID: 33126942
A High Performance Liquid Chromatographic (method A) and Ultra Violet spectrophotometric (method B) method were developed and…
Expand
2011
2011
REVERSE PHASE –HIGH PERFORMANCE LIQUID CHROMATOGRAPHY AND ULTRA VIOLET SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF RALTEGRAVIR POTASSIUM IN BULK
T.Raghupathi T.Sudha
2011
Corpus ID: 138288609
A High Performance Liquid Chromatographic (method A) and Ultra Violet spectrophotometric (method B) method were developed and…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and findings in experimental and clinical…
2010
Corpus ID: 39984859
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2010
2010
New Antimicrobial Agents Approved by the U.S. Food and Drug Administration from 2007 to 2009 and New Indications for Previously Approved Agents
Antimicrobial Agents and Chemotherapy
2010
Corpus ID: 206702879
12 Apr 2007 Altabax (topical ointment) Retapamulin Glaxo Group For topical treatment of impetigo due to Staphylococcus aureus…
Expand
2009
2009
Process for preparing amorphous raltegravir potassium
Bandi Parthasaradhi Reddy
,
K. R. Reddy
,
R. R. Reddy
,
D. Reddy
,
K. S. Reddy
2009
Corpus ID: 203933410
Process for preparing raltegravir potassium in amorphous form comprising: a. raltegravir potassium stirring in water; b. removing…
Expand
2008
2008
A polar radical pair pathway to assemble the pyrimidinone core of the HIV integrase inhibitor raltegravir potassium.
P. Pye
,
Y. Zhong
,
Gavin O. Jones
,
R. Reamer
,
K. Houk
,
D. Askin
Angewandte Chemie
2008
Corpus ID: 30719278
The UN and WHO currently estimate that 40 million people are living with HIV/AIDS worldwide. Combination therapies using reverse…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE